Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,993
  • Shares Outstanding, K 3,484
  • Annual Sales, $ 0 K
  • Annual Income, $ -65,010 K
  • 60-Month Beta -3.51
  • Price/Sales 111.58
  • Price/Cash Flow N/A
  • Price/Book 0.67
Trade IBIO with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 335.75%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6700 +4.67%
on 04/19/24
4.9800 -64.90%
on 03/28/24
+0.5980 (+52.00%)
since 03/26/24
3-Month
1.0500 +66.48%
on 03/20/24
4.9800 -64.90%
on 03/28/24
+0.5680 (+48.14%)
since 01/26/24
52-Week
1.0214 +71.14%
on 01/18/24
22.8000 -92.33%
on 05/02/23
-20.0520 (-91.98%)
since 04/26/23

Most Recent Stories

More News
Pre-Market Brief: Stocks Slide As Growth Fears Deepen

December S&P 500 futures (ESZ22) are trending down -0.16% this morning after three major US benchmark indices finished the regular session in the red as market participants fretted over Federal Reserve...

ESZ22 : 3,871.47s (-0.66%)
META : 439.21 (-0.49%)
BAC : 38.10 (+0.50%)
JPM : 194.00 (+0.33%)
MDB : 382.79 (+4.55%)
MMAT : 3.00 (-0.33%)
SWBI : 17.07 (+1.07%)
IBIO : 1.7600 (+2.33%)
ABNB : 164.67 (+1.02%)
Pre-Market Brief: Stocks Plunge On Mounting Recession Risks

December S&P 500 futures (ESZ22) are trending down -0.68% this morning after the Dow Jones Industrial Average and S&P 500 index continued to fall deeper into bear-market territory as investors digested...

ESZ22 : 3,871.47s (-0.66%)
BIIB : 207.95 (+2.71%)
RUM : 6.72 (+2.75%)
MNMD : 8.60 (+0.94%)
SAND : 5.62 (+2.37%)
IBIO : 1.7600 (+2.33%)
iBio (IBIO) Q3 2022 Earnings Call Transcript

IBIO earnings call for the period ending March 31, 2022.

IBIO : 1.7600 (+2.33%)
iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update

BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)
iBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022

BRYAN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)
iBio to Participate in the Oppenheimer 32nd Annual Healthcare Conference

BRYAN, Texas, March 11, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)
Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of...

PFNX : 12.75 (-0.08%)
IBIO : 1.7600 (+2.33%)
iBio Reports Fiscal Second Quarter 2022 Financial Results and Provides Corporate Update

BRYAN, Texas, Feb. 14, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)
iBio to Report Fiscal 2022 Second Quarter Financial Results and Provide Corporate Update on Monday, February 14, 2022

BRYAN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)
iBio Announces Participation in the H.C. Wainwright BioConnect Conference

BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...

IBIO : 1.7600 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

3rd Resistance Point 2.0733
2nd Resistance Point 1.9867
1st Resistance Point 1.8533
Last Price 1.7600
1st Support Level 1.6333
2nd Support Level 1.5467
3rd Support Level 1.4133

See More

52-Week High 22.8000
Fibonacci 61.8% 14.4806
Fibonacci 50% 11.9107
Fibonacci 38.2% 9.3408
Last Price 1.7600
52-Week Low 1.0214

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar